XML 484 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Unrecognized Compensation Expense

Unrecognized compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2020 was as follows:

 

    As of December 31, 2020  
    Restricted Stock Awards     Common Stock Awards     Common Equity Awards     Outside Options     Publisher Partner Warrants     ABG Warrants     Totals  
Unrecognized compensation expense   $ 81,620     $ 371,932     $ 19,874,675     $ 283,388     $ -     $ 3,214,102     $ 23,825,717  
Weighted average period expected to be recognized (in years)     0.95       0.67       1.87       1.18       -       2.38       1.91  
ABG Warrants [Member]  
Schedule of Fair Value of Stock Options Assumptions

The fair value of the ABG Warrants issued during the year ended December 31, 2019 were calculated using the Monte Carlo model by an independent appraisal firm under the Probability Weighted Scenarios utilizing the following assumptions:

 

    Up-list     No Up-list  
Risk-free interest rate     2.00% – 2.10 %     2.00% – 2.10 %
Expected dividend yield     0.00 %     0.00 %
Expected volatility     51.00% – 52.00 %     121.00% – 123.00 %
Expected life     6.0 – 7.3 years       6.2 – 7.3 years  
Schedule of Warrants Activity

A summary of the ABG Warrant activity during the years ended December 31, 2020 and 2019 is as follows:

 

    Number of Shares    

Weighted Average

Exercise

    Weighted Average Remaining Contractual Life  
    Unvested     Vested     Price     (in years)  
ABG Warrants outstanding at January 1, 2019     -       -     $ -          
Issued     21,989,844       -       0.63          
ABG Warrants outstanding at December 31, 2019     21,989,844       -       0.63       9.46  
Vested     (2,198,985 )     2,198,985       0.63          
ABG Warrants outstanding at December 31, 2020     19,790,859       2,198,985       0.63       8.46  
Summary of Stock-based Compensation

Stock–based compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2020 and 2019 are summarized as follows:

 

    Year Ended December 31, 2020  
    Restricted     Common     Common           Publisher              
    Stock     Stock     Equity     Outside     Partner     ABG        
    Awards     Awards     Awards     Options     Warrants     Warrants     Totals  
Cost of revenue   $ 163,181     $ 156,043     $ 3,975,625     $ 8,394     $ 36,673     $ -     $ 4,339,916  
Selling and marketing     1,486,722       114,640       2,454,432       272,431       -       -       4,328,225  
General and administrative     317,982       615,604       3,439,803       150,577       -       1,449,074       5,973,040  
Total costs charged to operations     1,967,885       886,287       9,869,860       431,402       36,673       1,449,074       14,641,181  
Capitalized platform development     361,519       178,284       1,062,792       6,400       -       -       1,608,995  
Total stock-based compensation   $ 2,329,404       1,064,571     $ 10,932,652     $ 437,802     $ 36,673     $ 1,449,074     $ 16,250,176  

 

    Year Ended December 31, 2019  
    Restricted     Common     Common           Publisher              
    Stock     Stock     Equity     Outside     Partner     ABG        
    Awards     Awards     Awards     Options     Warrants     Warrants     Totals  
Cost of revenue   $ 122,192     $ 44,520     $ 774,632     $ 1,580     $ 50,828     $ -     $ 993,752  
Selling and marketing     34,393       100,388       455,280       242,399       -       -       832,460  
General and administrative     2,541,468       1,660,607       3,383,338       157,359       -       795,803       8,538,575  
Total costs charged to operations     2,698,053       1,805,515       4,613,250       401,338       50,828       795,803       10,364,787  
Capitalized platform development     535,004       175,837       590,618       5,931       -       -       1,307,390  
Total stock-based compensation   $ 3,233,057       1,981,352     $ 5,203,868     $ 407,269     $ 50,828     $ 795,803     $ 11,672,177  
Stock Options Outside 2016 Plan and 2019 Plan [Member]  
Schedule of Fair Value of Stock Options Assumptions

The fair value for the outside options granted during the year ended December 31, 2019 were calculated using the Black-Scholes option pricing model for the time-based and performance-based awards by an independent appraisal firm under the Probability Weighted Scenarios utilizing the following assumptions:

 

    Up-list     No Up-list  
Risk-free interest rate     2.49% –2.57 %     2.49% – 2.57 %
Expected dividend yield     0.00 %     0.00 %
Expected volatility     74.00% – 95.00 %     122.00% – 142.00 %
Expected life     3.0 – 5.8 years       3.0 – 5.8 years  
Summary of Stock Option Activity

A summary of outside option activity during the years ended December 31, 2020 and 2019 is as follows:

 

                Weighted  
                Average  
          Weighted     Remaining  
    Number     Average     Contractual  
    of     Exercise     Life  
    Shares     Price     (in Years)  
Outside options outstanding at January 1, 2019     2,414,000     $ 0.36       9.94  
Granted     1,500,000       0.57          
Exercised     (2,000 )     0.35          
Forfeited     (180,000 )     0.35          
Expired     (7,333 )     0.35          
Outside options outstanding at December 31, 2019     3,724,667       0.21       9.04  
Forfeited     (195,333 )     0.46          
Expired     (477,334 )     0.39          
Outside options outstanding at December 31, 2020     3,052,000       0.46       8.07  
Outside options exercisable at December 31, 2020     2,376,333       0.43       6.20  
Outside options not vested at December 31, 2020     675,667                  
Schedule of Exercise Prices of Common Stock Options

The exercise prices of outside options outstanding and exercisable are as follows as of December 31, 2020:

 

Exercise   Outstanding     Exercisable  
Price   (Shares)     (Shares)  
 Under $1.00     3,052,000       2,376,333  
Publisher Partner Warrant [Member]  
Schedule of Exercise Prices of Common Stock Options

The exercise prices of the Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2020.

 

Exercise     Outstanding     Exercisable  
Price     (Shares)     (Shares)  
  Under $1.00       40,000       40,000  
$ 1.01 to $1.25       465,419       275,419  
$ 1.26 to $1.50       68,277       68,277  
$ 1.51 to $1.75       110,318       27,818  
$ 1.76 to $2.00       104,449       50,449  
$ 2.01 to $2.25       1,078       1,078  
          789,541       463,041  
Schedule of Warrants Activity

A summary of the Publisher Partner Warrants activity during the years ended December 31, 2020 and 2019 is as follows:

 

                Weighted  
                Average  
          Weighted     Remaining  
    Number     Average     Contractual  
    of     Exercise     Life  
    Shares     Price     (in Years)  
Publisher Partner Warrants outstanding at January 1, 2019     1,017,140     $ 1.47       3.26  
Forfeited     (77,599 )     1.62          
Publisher Partner Warrants outstanding at December 31, 2019     939,541       1.46       2.57  
Forfeited     (150,000 )                
Publisher Partner Warrants outstanding at December 31, 2020     789,541       1.34       1.50  
Publisher Partner Warrants exercisable at December 31, 2020     463,041       1.31       1.52  
Publisher Partner Warrants not vested at December 31, 2020     326,500                  
Publisher Partner Warrants available for future grants at December 31, 2020     1,210,459                  
Common Stock Awards [Member]  
Schedule of Fair Value of Stock Options Assumptions

The fair value of common stock awards granted during the year ended December 31, 2020 were calculated using the Black-Scholes option pricing model under the Probability Weighted Scenarios utilizing the following assumptions:

 

    Up-list     No Up-list  
Risk-free interest rate     0.45 %     0.45 %
Expected dividend yield     0.00 %     0.00 %
Expected volatility     71.00 %     132.00 %
Expected life     6.0 years       6.0 years  
Summary of Stock Option Activity

A summary of the common stock award activity during the years ended December 31, 2020 and 2019 is as follows:

 

                Weighted  
                Average  
          Weighted     Remaining  
    Number     Average     Contractual  
    of     Exercise     Life  
    Shares     Price     (in Years)  
Common stock awards outstanding at January 1, 2019     9,405,541     $ 0.61       9.30  
Exercised     (25,000 )     0.17          
Forfeited     (1,197,776 )     0.73          
Expired     (118,204 )     1.09          
Common stock awards outstanding at December 31, 2019     8,064,561       0.62       8.34  
Granted     234,000       0.90          
Exercised     (6,944 )     0.56          
Forfeited     (601,179 )     1.09          
Expired     (788,101 )     0.53          
Common stock awards outstanding at December 31, 2020     6,902,337       0.86       7.50  
Common stock awards exercisable at December 31, 2020     6,027,418       0.90       7.47  
Common stock awards not vested at December 31, 2020     874,919                  
Common stock awards available for future grants at December 31, 2020     3,097,663                  
Schedule of Exercise Prices of Common Stock Options

The exercise prices under the 2016 Plan for the common stock awards outstanding and exercisable are as follows as of December 31, 2020:

 

Exercise     Outstanding     Exercisable  
Price     (Shares)     (Shares)  
  Under $1.00       4,825,750       3,982,816  
$ 1.01 to $1.25       780,751       779,843  
$ 1.51 to $1.75       250,000       229,479  
$ 1.76 to $2.00       924,169       913,613  
$ 2.01 to $2.25       121,667       121,667  
          6,902,337       6,027,418  
Common Equity Awards [Member]  
Schedule of Fair Value of Stock Options Assumptions

The fair value of common equity awards granted during the years ended December 31, 2020 and 2019 were calculated using the Black-Scholes option pricing model for the time-based and performance-based awards by an independent appraisal firm under the Probability Weighted Scenarios utilizing the following assumptions:

 

    December 31, 2020     December 31, 2019  
    Up-list     No Up-list     Up-list     No Up-list  
Expected life     0.20% - 0.79 %     0.20% - 0.79 %     1.51% - 2.59 %     1.51% - 2.59
Risk-free interest rate     0.00 %     0.00 %     0.00 %     0.00 %
Volatility factor     61.00% - 91.00 %     61.00% - 142.00 %     69.00% - 95.00 %     119.00% - 149.00 %
Dividend rate     3.0 – 6.7 years       3.0 – 6.7 years       3.0 – 6.0 years       3.0 – 6.0 years  

 

The fair value of common equity awards granted during the year ended December 31, 2019 were calculated using the Monte Carlo model for the market-based awards by an independent appraisal firm under the Probability Weighted Scenarios utilizing the following assumptions:

 

    Up-list     No Up-list  
Expected life     2.20% - 2.70 %     2.16% - 2.71 %
Risk-free interest rate     0.00 %     0.00 %
Volatility factor     140.00% - 146.00 %     110.00 %
Dividend rate     10.0 years       10.0 years  
Summary of Stock Option Activity

A summary of the common equity award activity during the years ended December 31, 2020 and 2019 is as follows:

 

                Weighted  
                Average  
          Weighted     Remaining  
    Number     Average     Contractual  
    of     Exercise     Life  
    Shares     Price     (in Years)  
Common equity awards outstanding at January 1, 2019     -     $ -       -  
Granted     68,180,863       0.53          
Forfeited     (3,167,218 )     0.53          
Common equity awards outstanding at December 31, 2019     65,013,645       0.53       9.43  
Granted     25,393,768       0.71          
Forfeited     (8,342,377 )     0.61          
Expired     (2,722 )     0.56          
Common equity awards vested at December 31, 2020     82,062,314       0.58       8.65  
Common equity awards exercisable at December 31, 2020     13,608,686       0.54       8.49  
Common equity awards not vested at December 31, 2020     68,453,628                  
Common equity awards available for future grants at December 31, 2020     2,937,686                  
Schedule of Exercise Prices of Common Stock Options

The exercise prices under the 2019 Plan for the common equity awards outstanding and exercisable are as follows as of December 31, 2020:

 

Exercise   Outstanding     Exercisable  
Price   (Shares)     (Shares)  
No exercise price     250,000       250,000  
Under $1.00     81,812,314       13,358,686  
      82,062,314       13,608,686  
Restricted Stock Units [Member]  
Schedule of Restricted Stock Units Activity

A summary of the restricted stock unit activity during the years ended December 31, 2020 and 2019 is as follows:

 

    Number of Shares     Weighted Average Grant-Date  
    Unvested     Vested     Fair Value  
Restricted stock units outstanding at January 1, 2019     -       -     $ -  
Granted     2,399,997       -       0.45  
Restricted stock units outstanding at December 31, 2019     2,399,997       -       0.45  
Forfeited     (2,399,997 )     -          
Restricted stock units outstanding at December 31, 2020     -       -       -